CoverageForm 410-K10-Q8-K13D13G13F

JBTM · Jbt Marel Corp - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · JBTM

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$936.00M-$1.00B$934.80M$854.10M-$453.80M$402.30M$392.30M-
Cost of Revenue$607.00M-$290.20M$600.60M$252.00M-----
Gross Profit$329.00M-$711.10M$334.20M$602.10M-----
R&D--$5.40M$30.90M$6.40M-----
SG&A$261.00M-$222.00M$250.40M$281.70M-$117.00M$116.20M$110.10M-
Total Operating Expenses----------
D&A--------$22.10M-
Operating Income$68.00M-$102.10M$48.40M($33.40M)-$46.80M$26.80M$29.10M-
Interest Expense--$24.70M$31.80M$42.40M-$4.10M$8.20M$2.90M-
Income Tax$15.00M-$17.10M$7.90M($46.20M)-$9.50M($3.30M)$8.10M-
Net Income$45.00M-$66.00M$3.40M($173.00M)-$38.90M$30.70M$22.80M-
EPS - Basic$0.86-$1.26$0.07($3.35)-$1.22$0.96$0.71-
EPS - Diluted$0.86-$1.26$0.07($3.35)-$1.21$0.95$0.71-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$168.00M$167.90M$114.90M$111.80M$1.23B$1.23B$534.50M$474.30M$479.00M$483.30M
Accounts Receivable$438.00M$442.90M$434.60M$413.70M$399.30M$239.70M$237.90M$228.40M$220.70M$214.40M
Inventory$667.00M$643.70M$669.40M$661.10M$613.50M$233.10M$259.00M$258.70M$250.20M$238.90M
Accounts Payable$294.00M$261.90M$300.50M$288.90M$282.20M$131.00M$144.70M$135.60M$142.40M$134.60M
Current Assets$1.68B$1.58B$1.54B$1.53B$1.49B$1.86B$1.21B$1.13B$1.10B$1.10B
Total Assets$8.16B$8.19B$8.20B$8.25B$8.00B$3.41B$2.79B$2.69B$2.69B$2.71B
Current Liabilities$1.66B$1.62B$1.65B$1.64B$1.18B$535.50M$473.40M$442.90M$466.10M$484.40M
Long-term Debt$1.43B$1.47B$1.50B$1.51B$1.97B$1.25B$648.30M$647.60M$647.00M$646.40M
Total Liabilities----------
Stockholders' Equity$4.48B$4.46B$4.42B$4.37B$4.11B$1.54B$1.59B$1.52B$1.49B$1.49B
Retained Earnings$1.50B$1.46B$1.42B$1.36B$1.36B$1.54B$1.55B$1.51B$1.48B$1.46B

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$34.00M---$34.40M---$10.40M-
Investing Cash Flow($19.00M)---($7.20M)---($7.20M)-
Financing Cash Flow($54.00M)---$621.40M---($6.10M)-
CapEx$26.00M---$20.00M---$10.50M-
Free Cash Flow$8.00M---$14.40M---($100.0K)-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin35.1%-71.0%35.8%70.5%-----
Operating margin7.3%-10.2%5.2%-3.9%-10.3%6.7%7.4%-
EBITDA margin--------13.1%-
Net margin4.8%-6.6%0.4%-20.3%-8.6%7.6%5.8%-
Free cash flow margin0.9%---1.7%----0.0%-
FCF / Net income0.18----0.08----0.00-
R&D / Revenue--0.5%3.3%0.7%-----
SG&A / Revenue27.9%-22.2%26.8%33.0%-25.8%28.9%28.1%-
Effective tax rate25.0%-20.6%69.9%--19.6%-12.0%26.2%-
Return on assets0.6%-0.8%0.0%-2.2%-1.4%1.1%0.8%-
Return on equity1.0%-1.5%0.1%-4.2%-2.5%2.0%1.5%-
Return on invested capital0.9%-1.4%0.4%-0.4%-1.7%1.2%1.0%-
Liquidity
Current ratio1.010.980.930.931.263.482.552.542.372.27
Quick ratio0.610.580.530.530.743.042.001.961.831.78
Cash ratio0.100.100.070.071.042.291.131.071.031.00
Leverage
Debt / Equity0.320.330.340.350.480.810.410.430.430.43
Debt / Assets0.180.180.180.180.250.370.230.240.240.24
Debt / EBITDA--------12.64-
Interest coverage--4.1x1.5x-0.8x-11.4x3.3x10.0x-
Equity multiplier1.821.831.851.891.952.211.761.771.801.82
Liabilities / Assets----------
Efficiency
Asset turnover0.11-0.120.110.11-0.160.150.15-
Inventory turnover0.91-0.430.910.41-----
Days sales outstanding171d-158d162d171d-191d207d205d-
Days inventory outstanding401d-842d402d889d-----
Days payable outstanding177d-378d176d409d-----
Cash conversion cycle395d-622d388d651d-----
Valuation
P / E148.7x-111.5x1718.0x------
P / B1.5x-1.7x1.4x------
P / S7.2x-7.3x6.7x------
EV / EBITDA----------
Growth
Revenue growth (YoY)9.6%-120.6%132.4%117.7%-12.4%-5.9%-25.9%-
Revenue CAGR (3y)20.9%-21.7%19.9%22.1%--1.7%-5.4%-2.1%-
Revenue CAGR (5y)17.5%-19.0%17.8%13.3%--1.5%-4.0%-1.2%-
Gross profit growth (YoY)-45.4%---------
Operating income growth (YoY)--118.2%80.6%--30.0%-38.2%-27.3%-
Net income growth (YoY)--69.7%-88.9%---91.7%-1.0%-10.9%-
EPS growth (YoY)--4.1%-92.6%---91.7%-2.1%-11.3%-
EPS CAGR (3y)2.4%-5.6%-59.3%--10.0%0.0%-5.5%-
EPS CAGR (5y)0.5%-18.5%-41.4%--3.1%-2.0%3.1%-
FCF growth (YoY)-44.4%---------
FCF CAGR (5y)-36.4%---25.6%-----
Book value growth (YoY)9.1%189.1%178.9%188.0%175.5%3.7%15.4%64.9%67.4%72.6%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$3.80B total
Prepared Food And Beverage Solutions$2.08B · 54.8%
Protein Solutions$1.72B · 45.2%

Product / service

$3.36B total
Product$1.64B · 48.9%
Recurring$900.30M · 26.8%
Non Recurring$815.90M · 24.3%

Geographic

$5.51B total
Non Us$2.36B · 42.8%
US$1.44B · 26.1%
Europe Middle Eastand Africa$827.50M · 15.0%
North America$544.40M · 9.9%
Latin America$196.50M · 3.6%
Asia Pacific$147.80M · 2.7%

Peer comparison

Same SIC group: Special Industry Machinery (No Metalworking Machinery)

CompanyRevenue (last FY)Net marginROE
NVT$3.89B18.2%19.0%
KAI$1.05B9.7%10.4%
PNR$4.18B15.7%16.9%

Comparing JBT MAREL Corp against the 3 most active filers in the same SIC group.

Dividends

$0.40/share trailing 12 months · 0.0% YoY

Ex-datePer share
May 26, 2026$0.1000
Mar 9, 2026$0.1000
Dec 15, 2025$0.1000
Aug 18, 2025$0.1000
May 27, 2025$0.1000
Mar 10, 2025$0.1000
Dec 13, 2024$0.1000
Aug 19, 2024$0.1000
May 22, 2024$0.1000
Mar 8, 2024$0.1000
Dec 15, 2023$0.1000
Aug 18, 2023$0.1000
May 24, 2023$0.1000
Mar 3, 2023$0.1000
Dec 16, 2022$0.1000
Aug 19, 2022$0.1000
May 25, 2022$0.1000
Mar 4, 2022$0.1000
Dec 10, 2021$0.1000
Aug 20, 2021$0.1000
May 26, 2021$0.1000
Mar 5, 2021$0.1000
Dec 11, 2020$0.1000
Aug 21, 2020$0.1000